TianTan vaccinia virus-based EBV vaccines targeting both latent and lytic antigens elicits potent immunity against lethal EBV challenge in humanized mice

MLA

Xinyu Zhang, et al. “TianTan Vaccinia Virus-Based EBV Vaccines Targeting Both Latent and Lytic Antigens Elicits Potent Immunity against Lethal EBV Challenge in Humanized Mice.” Emerging Microbes and Infections, vol. 13, no. 1, Dec. 2024. EBSCOhost, https://doi.org/10.1080/22221751.2024.2412640.

APA

Xinyu Zhang, Yanhong Chen, Shuhui Wang, Ling Zhong, Zheng Xiang, Xiao Zhang, Shanshan Zhang, Xiang Zhou, Wanlin Zhang, Yan Zhou, Qiuting Zhang, Jingtong Liang, Yanran Luo, Yufei Wang, Ling Chen, Xiaoping Ye, Qisheng Feng, Mu-Sheng Zeng, Ying Liu, … Miao Xu. (2024). TianTan vaccinia virus-based EBV vaccines targeting both latent and lytic antigens elicits potent immunity against lethal EBV challenge in humanized mice. Emerging Microbes and Infections, 13(1). https://doi.org/10.1080/22221751.2024.2412640

Chicago

Xinyu Zhang, Yanhong Chen, Shuhui Wang, Ling Zhong, Zheng Xiang, Xiao Zhang, Shanshan Zhang, et al. 2024. “TianTan Vaccinia Virus-Based EBV Vaccines Targeting Both Latent and Lytic Antigens Elicits Potent Immunity against Lethal EBV Challenge in Humanized Mice.” Emerging Microbes and Infections 13 (1). doi:10.1080/22221751.2024.2412640.